Skip to main content
. 2016 Jun 2;7(28):43534–43545. doi: 10.18632/oncotarget.9780

Figure 6. Reintroduction of E2F5 impairs the FOXN3-induced suppression of HCC cell proliferation.

Figure 6

(A), (B) and (C) Western blot and qPCR analyses of FOXN3 or E2F5 expression in E2F5-trasfected HCC cells or controls. (D) Cell growth at different time points (every one day interval) was analyzed using an MTT assay and colony formation assay. *P < 0.05, **P < 0.01.